Clinical and epidemiological data for bone metastases

被引：1
作者：
Debiais, F. [1 ]
机构：
[1] Univ Poitiers, CHU Poitiers, Serv Rhumatol, F-86021 Poitiers, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 03期
关键词：
Bone metastasis; Epidemiology; Skeletal-related events; SKELETAL-RELATED EVENTS; BREAST-CANCER PATIENTS; LONG-TERM EFFICACY; PROGNOSTIC-FACTORS; ZOLEDRONIC ACID; SOLID TUMORS; COMPLICATIONS; MORTALITY; SURVIVAL; CARCINOMA;
D O I：
10.1007/s10269-015-2488-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bone is a frequent site for metastases in patients with advanced solid tumours, above all concerning prostate, breast, and lung cancers. Bone metastases are often responsible for pain and can be at the origin of skeletal-related events (SRE), associated with morbidity, decrease in quality of life and survival, highlighting the importance of a rapid diagnosis of cancer and treatment in case of bone metastases so as to decrease the risk of these complications.
引用
收藏
页码：63 / 68
页数：6
相关论文
共 50 条
[31]   The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence [J].
Liu, Youjun ;
Chen, Huanshi ;
Chen, Tong ;
Qiu, Guowen ;
Han, Yu .
FRONTIERS IN ONCOLOGY, 2024, 14
[32]   High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases [J].
Lagana, Marta ;
Gurizzan, Cristina ;
Roca, Elisa ;
Cortinovis, Diego ;
Signorelli, Diego ;
Pagani, Filippo ;
Bettini, Anna ;
Bonomi, Lucia ;
Rinaldi, Silvia ;
Berardi, Rossana ;
Filetti, Marco ;
Giusti, Raffaele ;
Pilotto, Sara ;
Milella, Michele ;
Intagliata, Salvatore ;
Baggi, Alice ;
Cortellini, Alessio ;
Soto Parra, Hector ;
Brighenti, Matteo ;
Petrelli, Fausto ;
Bennati, Chiara ;
Bidoli, Paolo ;
Garassino, Marina Chiara ;
Berruti, Alfredo .
FRONTIERS IN ONCOLOGY, 2020, 10
[33]   Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity? [J].
Deberne, Melanie ;
Ropert, Stanislas ;
Billemont, Bertrand ;
Daniel, Catherine ;
Chapron, Jeanne ;
Goldwasser, Francois .
BMC CANCER, 2014, 14
[34]   A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe [J].
Body, Jean-Jacques ;
von Moos, Roger ;
Rider, Alex ;
Hallworth, Pamela ;
Bhowmik, Debajyoti ;
Gatta, Francesca ;
Hechmati, Guy ;
Qian, Yi .
JOURNAL OF BONE ONCOLOGY, 2019, 14
[35]   Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States [J].
Hernandez, Rohini K. ;
Wade, Sally W. ;
Reich, Adam ;
Pirolli, Melissa ;
Liede, Alexander ;
Lyman, Gary H. .
BMC CANCER, 2018, 18
[36]   Validation of Algorithms to Identify Bone Metastases Using Administrative Claims Data in a Japanese Hospital [J].
Hirano, Takahiro ;
Saito, Naoko ;
Wakabayashi, Ryozo ;
Kuwatsuru, Ryohei .
DRUGS-REAL WORLD OUTCOMES, 2023, 10 (02) :187-194
[37]   Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis [J].
Gong, Linlin ;
Xu, Liming ;
Yuan, Zhiyong ;
Wang, Zhongqiu ;
Zhao, Lujun ;
Wang, Ping .
JOURNAL OF BONE ONCOLOGY, 2019, 19
[38]   Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases [J].
Carter, John A. ;
Ji, Xiang ;
Botteman, Marc F. .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (04) :483-496
[39]   Bone metastases in thyroid cancer [J].
Iniguez-Ariza, Nicole M. ;
Bible, Keith C. ;
Clarke, Bart L. .
JOURNAL OF BONE ONCOLOGY, 2020, 21
[40]   Bisphosphonates as Treatment of Bone Metastases [J].
Holen, Ingunn ;
Coleman, Robert E. .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (11) :1262-1271
12345